Pfizer Buys Out Wyeth
On January 26th, 2009, Pfizer, a multi-billion dollar company agreed to buy out Wyeth for $68 billion. Pfizer, a company known for its large dividends, upset investors by slashing their dividends 16 cents per share. “The dividend had led the industry, although the company maintains it still remains competitive with other drugmakers.” With the merge of these incredibly large pharmaceutical companies, it was seen that a wave of consolidation could have potentially started for pharmaceutical companies. This merger brings up two questions for myself:
-Do you believe that Wyeth’s IT architecture and global outlook would have been continued or scrapped for Pfizer’s own plan?
-Do you feel that (knowing how large and successful Pfizer is today) that this acquisition was in Wyeth’s best interest for reaching a global market?